Tauopathy has been found to have a critical relationship with the clinical symptoms of patients with dementia [9], and thus represents a possible means for evaluating the severity/progression of clinical dementia in AD patients by using an in vivo PET imaging technique to examine tau pathology. Here, MAPT is linked to tauopathy.